Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0002014440-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-03 | INDV | Anderson Woodrow D | CAO | F - Tax | $31.98 | -11.0K | 24.6K | -31% | -$350.7K |
| DM | 2026-03-05 | 2026-03-03 | INDV | Anderson Woodrow D | CAO | M - OptEx | — | +24.3K | 29.7K | +455% | — |
| DM | 2026-03-05 | 2026-03-03 | INDV | Anderson Woodrow D | CAO | M - OptEx | — | -29.9K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | F | D | 8,283 | $31.98 | 21,374 | D | — | — | (F3) Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026. |
| 2 | Common | Common Stock | 2026-03-03 | M | A | 5,946 | — | 27,320 | D | — | — | (F2) Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Common | Common Stock | 2026-03-03 | F | D | 2,682 | $31.98 | 24,638 | D | — | — | (F4) Shares used to satisfy tax withholding obligations associated with the vesting of restricted stock units on March 3, 2026. |
| 4 | Common | Common Stock | 2026-03-03 | M | A | 18,364 | — | 29,657 | D | — | — | (F1) Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount. (F2) Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 5 | Derivative | Performance Stock Units | 2026-03-03 | M | D | 23,975 | — | 0 | D | $0.00 · 2026-03-03 to — | 23,975 Common Stock | (F2) Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F1) Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount. |
| 6 | Derivative | Restricted Stock Units | 2026-03-03 | M | D | 5,946 | — | 0 | D | $0.00 · 2026-03-03 to — | 5,946 Common Stock | (F2) Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F5) This award is fully vested in accordance with its terms, effective March 3, 2026. |